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Abstract
Background: Chronic diarrhoea is one of the most debilitating consequences of HIV infection in
sub-Saharan Africa and it carries a high mortality rate. We report unexpectedly low concentrations
of circulating aldosterone in 12 patients (6 men, 6 women) in the University Teaching Hospital,
Lusaka, who all had diarrhoea for over one month. Changes in serum electrolytes, blood pressure,
Karnofsky score and serum aldosterone concentration were being monitored during a short study
of responses to saline infusion (3 litres/24 h) over 72 hours.
Findings:  At baseline, 9/12 (75%) of the patients were hyponatraemic, 10/11 (91%) were
hypokalaemic, and 6/12 (50%) had undetectable aldosterone concentrations. Blood pressure and
Karnofsky score rose and creatinine concentration fell in response to the infusion.
Conclusion: Circulating aldosterone concentrations were inappropriately low and complicate the
profound electrolyte deficiencies resulting from chronic diarrhoea. Management of these
deficiencies needs to be more aggressive than is currently practised and consideration should be
given to a formal clinical trial of mineralocorticoid replacement in these severely ill patients. If the
inappropriately low aldosterone reflects a general adrenal failure, it may explain a considerable
proportion of the high mortality seen both before and after initiation of anti-retroviral therapy.
Findings
Rationale for the study
Intestinal infection leading to diarrhoea is one of the most
disabling and serious manifestations of AIDS. Although
anti-retroviral therapy reduces the incidence and severity
of diarrhoeal disease in HIV-infection, patients still
present to Zambian hospitals with advanced disease, and
mortality is still unacceptably high, even after initiating
anti-retroviral therapy [1]. In our previous experience,
mortality exceeds 20% per month, depending on the spe-
cific aetiological infection [2]. There have been many
analyses of the spectrum of opportunistic pathogen in
AIDS [3-5], but surprisingly little is known about the met-
abolic consequences of HIV infection in Africans.
It would be anticipated that patients with persistent diar-
rhoea would have sodium and water depletion and
hypokalaemia. During a series of studies of intestinal per-
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meability tests using monosaccharide and disaccharide
excretion ratios [6], we noted very low urine outputs in
AIDS patients on the point of discharge from hospital. We
then undertook fluid challenge studies in these patients,
as part of which we assessed electrolyte and mineralocor-
ticoid responses to the fluid challenge. We anticipated
that serum aldosterone would be high initially and would
fall to normal on successful salt and water repletion, but
instead we found inappropriately low aldosterone con-
centrations.
Investigations undertaken and methods
Twelve adult patients with diarrhoea of over one month
duration, who had all completed initial resuscitation with
fluids and were being prepared for discharge, were
included in the study. Only one patient per week (chosen
at random) was studied due to resource constraints, so
this study represents a subset of the patients with chronic
diarrhoea admitted to the hospital over the period of the
study. A further six patients were eligible for inclusion but
were excluded or withdrew for different reasons (see
Results). Patients were ineligible for study if there was any
evidence of overt cardiac dysfunction or fluid overload
(tachycardia, lung crepitations on auscultation, elevated
jugular venous pressure, abnormal electrocardiogram).
The study was performed in early 2004, just before the
advent of expanded access to anti-retroviral drugs in Zam-
bia. Most patients were unaware of their HIV status before
the counselling and testing which we carried out. The
study was approved by the Research Ethics Committee of
the University of Zambia.
Following written informed consent, patients were asked
to remain in hospital for the 72 hours of the study. Clini-
cal evaluation included full physical examination (with
particular reference to evidence of fluid overload as this
was an exclusion criterion), lying and standing blood
pressure, weight and height and electrocardiography. The
Karnofsky score [7] was used as a measure of global well-
being. Body Mass Index (BMI) was calculated as Quete-
let's index (kg/m2).
At 0800 on the first morning, a blood sample was drawn
while the patient was still supine, taken to the laboratory
for centrifugation, and aliquots of serum were stored at -
80°C. Further blood samples were taken after 24, 48 and
72 hours. Over each 24 hour period, an intravenous infu-
sion of 3 l normal saline was given and the clinical evalu-
ation repeated at 8 hourly intervals. All urine was
collected and 24 h sodium excretion estimated.
Analysis of sodium and potassium concentrations in
serum was performed on a flame photometer (Corning,
Halstead, Essex, UK); glucose and creatinine concentra-
tions were measured on a Cobas Mira multi-analyser
(Hoffman-LaRoche, Basel, Switzerland). Aldosterone was
assayed in serum samples in London by competitive radi-
oimmunoassay (Diagnostic Products Corporation, Los
Angeles, USA); the assay range is 69–3460 pmol/l and
precision is approximately 10% (K. Noonan, pers
comm.). Effective plasma osmolality (EPO), estimated
glomerular filtration rate (eGFR), and total sodium deficit
(TSD) were calculated using standard equations [8].
Data are presented as mean with either 95% confidence
intervals (CI) or standard deviation (SD). Statistical sig-
nificance was tested using a paired t test on values at the
beginning and end of the 72 hour infusion, and a P value
of < 0.05 regarded as significant.
Patient characteristics and responses to saline infusion
We recruited 18 patients into the study, which was con-
ducted in a side ward of a general medical ward in the
University Teaching Hospital, Lusaka, from February to
April 2004. Of these one had overt renal failure and was
excluded, 3 died during the first day and 2 withdrew
before the end of the study because of discomfort cause by
daily venepuncture. Several of the patients were severely
wasted (Table 1). Patients showed variable serum sodium
concentrations, with most having moderate and some
having profound hyponatraemia (Table 2). These patients
tolerated well the large volume of intravenous saline infu-
sion, and in response to this we observed a significant rise
in systolic (p = 0.02) but not diastolic (p = 0.29) blood
pressure (Fig 1), clinical improvement as reflected in ris-
ing Karnofsky score (p < 0.001; Fig 2), and falls in serum
creatinine (p = 0.04; Fig 3). Systolic blood pressure rose
from a mean of 96 (95%CI 72–121) mmHg at baseline to
105 (80–130) mmHg on day 4. There was no overall rise
in serum sodium or potassium concentrations: mean
(SD) serum sodium was 123 (12) mmol/l on day 1 and
127 (10) mmol/l on day 4, and serum potassium was 2.8
(1.0) mmol/l on day 1 and 2.7 (0.7) mmol/l on day 4.
However, some patients with the most extreme hyponat-
raemia did show such a rise (for example from 107 to 115
mmol/l and from 114 to 133 mmol/l). All patients dem-
onstrated either hyponatraemia at baseline or a progres-
sive rise in lying blood pressure in response to infusion,
and we conclude that all patients had evidence of sodium
depletion even though none showed postural hypoten-
sion. Further evidence for sodium depletion is that mean
urine sodium excretion in the first day was 13 mmol/24 h
but that it rose to 38 mmol/24 h after 3 days of saline infu-
sion. In the presence of low aldosterone concentrations
this probably signifies that sodium delivery to the distal
tubule was very low indeed. There was a mean positive
fluid balance of 1.5 litres/24 h, representing a total posi-
tive balance of 4.5 litres in 72 hours. Urine outputs in the
first 24 hours averaged 25.7 ml/kg in women and 30.2 ml/
kg in men.BMC Research Notes 2008, 1:10 http://www.biomedcentral.com/1756-0500/1/10
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Inappropriately low circulating aldosterone 
concentrations
Initial serum aldosterone concentrations were below the
threshold of detection in 6 (50%) of 12 patients. In an
additional patient with an apparently 'normal' aldoster-
one we suspect that the aldosterone was inappropriately
low in the face of low initial blood pressure which rose
after fluid challenge (Fig 4). In one patient with initially
undetectable aldosterone we observed the aldosterone
rise into the normal range, but in five it did not. In the
patients with initially normal or high aldosterone only
one showed a fall into the normal range.
Interpretation of findings
In this study, performed just before the widespread intro-
duction of anti-retroviral drugs, we found severe deficits
of sodium and potassium requiring aggressive therapy.
With large volumes of 0.9% saline given intravenously,
considerable improvements in well-being and in clinical
parameters were observed: average Karnofsky score rose
from 50 to 70, systolic blood pressure rose by 9 mmHg,
and creatinine fell by around 35%. While we cannot
exclude that the rise in Karnofsky score might have been
due to other aspects of care, including nursing, the fall in
creatinine suggests that renal perfusion had improved
markedly due to restoration of vascular and interstitial flu-
ids. The deficits of sodium in these patients appear to be
very large and, at least partly due to the chronicity of the
primary disease, difficult to correct. Despite the infusion
of an average of 1,350 mmol of Na, serum sodium con-
centrations remained low. We did not test for cortisol or
ACTH in the sera which we collected as the amount of
serum available was small, but we interpret the inappro-
priately low serum aldosterone concentrations to signify
that mineralocorticoid deficiency should be considered
likely in such patients. Supine aldosterone is not the most
sensitive test for adrenal failure, and a short Synacthen test
might have revealed even more. We cannot say just how
common this finding is as our sample is small and we do
not know if it is fully representative of all our patients with
persistent diarrhoea.
Table 2: Baseline biochemical characteristics
ID Na+ (mmol/l) K+ (mmol/l) Creatinine (μmol/l) Aldosterone (pmol/l) EPO (mosmol/kg) eGFR (ml/min) TSD (mmol)
1 107 2.4 79 730 215 37 330
2 132 2.3 139 <69 269 29 124
3 136 - 151 628 275 40 86
4 114 2.6 61 3035 232 87 507
5 121 5.9 118 <69 244 60 513
6 111 2.6 72 621 224 94 696
7 143 3.1 71 178 290 93 0
8 141 2.6 67 <69 285 117 0
9 112 2.0 131 545 225 62 1226
10 113 2.7 87 <69 227 88 1102
11 117 2.3 134 <69 250 45 856
12 123 2.1 63 <69 252 96 632
EPO, effective plasma osmolality; eGFR, estimated glomerular filtration rate; TSD, total sodium deficit. One K+ value is missing due to technical 
failure.
Table 1: Baseline clinical characteristics
ID Sex Age (yrs) HIV status WHO clinicalHIV stage BMI (kg/m2) Karnofsky score BP (lying) BP (standing) RR (/min) Pulse (i/e)
1 F 21 Positive 4 7.8 30 70/40 70/40 26 72/74
2 F 36 Positive 4 11.4 50 100/60 110/70 18 74/74
3 F 25 Positive 4 15.8 50 90/60 100/60 20 80/80
4 F 29 Positive 4 12.0 50 90/60 100/60 24 82/80
5 F 33 Positive 4 21.1 50 110/70 110/80 22 88/88
6 F 25 Positive 4 21.3 50 100/30 110/40 24 88/100
7 M 48 Positive 4 21.8 70 90/60 - 22 80/86
8 M 27 Positive 4 27.3 50 100/60 110/70 28 82/84
9 M 32 Positive 4 22.8 80 120/90 130/90 26 88/90
10 M 31 Positive 4 22.5 50 100/60 110/60 26 90/96
11 M 32 Positive 4 23.4 30 90/60 90/60 28 96/98
12 M 45 Positive 4 20.0 50 100/70 110/70 20 68/70
BMI, body mass index (Quetelet's index); BP, blood pressure; RR respiratory rate; i/e, inspiratory/expiratory.BMC Research Notes 2008, 1:10 http://www.biomedcentral.com/1756-0500/1/10
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The profound disturbances of electrolytes are difficult to
explain fully. The primary disorder, chronic diarrhoea,
leads to chronic sodium and potassium loss and total
body deficits of both these cations. In otherwise healthy
individuals the physiological response to these chronic
losses would be activation of the renin-angiotensin-aldos-
terone cascade which, together with release of vaso-
pressin, would lead to avid renal retention of salt and
water, together with potassium loss. Isolated adrenal fail-
ure, Addison's disease, would lead to sodium loss and
potassium retention. Only one of our patients, number 5
in Table 1, displayed this prototypical biochemical profile
at baseline. Most of the other patients had a combination
of hyponatraemia and hypokalaemia which seems to
indicate that electrolyte loss and low circulating aldoster-
one concentrations were operating concurrently. In
response to a saline challenge the sodium concentrations
Changes in aldosterone during saline infusion Figure 4
Changes in aldosterone during saline infusion. Serum 
aldosterone concentration before and after fluid challenge in 
A patients with initially normal or high concentrations, and B 
patients with initial concentrations below threshold of assay. 
In B, aldosterone concentrations remained below threshold 
in 4 patients whose lines overlap and are therefore indistin-
guishable. Reference range for serum aldosterone in supine 
patients is 135–400 pmol/l. Note that even 'normal' serum 
aldosterone would be inappropriately low in patients with 
sodium depletion.
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Changes in Karnofsky score during saline infusion Figure 2
Changes in Karnofsky score during saline infusion. 
Karnofsky score was recorded on days 1 and 4; mean and 
upper (up) and lower (lo) 95% confidence intervals; the rise 
was highly significant (p < 0.001).
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Changes in blood pressure during saline infusion Figure 1
Changes in blood pressure during saline infusion. 
Systolic (SysBP) and diastolic (DiaBP) blood pressure over 
the 4 days of the trial. Mean values are shown, together with 
upper (up) and lower (lo) 95% confidence intervals. The rise 
in systolic BP was significant (p = 0.02) but there was no sig-
nificant change in diastolic BP.
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Changes in creatinine during saline infusion Figure 3
Changes in creatinine during saline infusion. Changes 
in serum creatinine concentration over the course of the 4 
days of the fluid challenge; data are presented as mean with 
upper (up) and lower (lo) 95%CI. The rise was significant (p 
= 0.04).
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did not return to normal, suggesting either that the deficit
was very substantial or that ongoing losses were continu-
ing, or both. There was no postural hypotension, proba-
bly indicating that there was a degree of adaptation to the
chronic sodium deficiency and suggesting that ADH was
able to some degree to compensate, leading to partial res-
toration of circulating volume at the expense of hyponat-
raemia.
Discussion of findings in the context of available literature
In malnourished children, adrenocortical hormone con-
centrations in plasma are, in general, appropriately ele-
vated [9], but adults with tuberculosis in Africa frequently
have adrenal failure. In a study in Tanzania, adrenal fail-
ure was found in 16 of 50 patients with pulmonary tuber-
culosis, though information on HIV status was not
available [10]. To our knowledge no information is avail-
able on adrenal dysfunction in HIV infected Africans with
persistent diarrhoea, in whom malnutrition can be severe
[11]. Adrenal failure in AIDS was described in the 1980s,
but it remains an under-diagnosed problem. Adrenal fail-
ure in AIDS was recognised first in the 1980s [12] due to
cytomegalovirus (CMV) and it has now been recognised
as an important complication of HIV infection [13,14].
CMV [15], tuberculosis [10], Pneumocystis jiroveci, toxo-
plasmosis, and lymphoma have all been implicated [16].
Studies in Africa are much more limited, largely due to the
lack of availability of reliable endocrine assays. Post-mor-
tem studies in Africa suggest that TB is frequently undiag-
nosed during life [17] and adrenal tuberculosis is
common in Zambian adults with AIDS (V. Mudenda, pers
comm.). Recent evidence has indicated that routine tests
for adrenal insufficiency may be inadequate and may
under-diagnose the condition [18].
We have previously demonstrated that patients with
AIDS-related diarrhoea often have severe undernutrition
and very high mortality rates [2]. The mortality rate in this
study was of great concern. Although based on only 3
deaths, it represents a 17% death rate in one day. We do
not think it was due to the intervention as no patient
developed fluid overload, but we cannot rule this out. It
may be due to the advanced disease which these patients
undoubtedly had, particularly severe electrolyte deficien-
cies and other ions such as magnesium may be important.
It is worrying that the patients we recruited were on the
point of discharge from hospital, as this would indicate
that we have hitherto seriously underestimated the sever-
ity of their clinical condition. As patients with AIDS often
present to health care workers with late stage disease, we
foresee that management of these patients will present a
challenge for years to come despite improved access to
anti-retroviral therapy. There are very few hospitals in
Africa which can perform hormone assays, but we pro-
pose that formal controlled trials of mineralocorticoid
replacement be set up to find if such a strategy would
reduce mortality.
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